Home > Insider Trading > Filing (0001209191-19-023521)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1755237	Cyclerion Therapeutics Inc.	CYCN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1478244	G Mark Currie	C/O Cyclerion Therapeutics, Inc. 301 Binney Street Cambridge MA 02142	President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-04-01	51,648	$0.00	51,648	No	4	A	Direct
Common Stock	Acquisiton	2019-04-02	270,107	$14.81	321,755	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	888	$0.00	888	$12.39
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	37,286	$0.00	37,286	$12.23
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	17,491	$0.00	17,491	$16.21
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	27,773	$0.00	27,773	$14.40
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	9,930	$0.00	9,930	$15.54
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	13,125	$0.00	13,125	$17.20
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	2,500	$0.00	2,500	$17.20
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	50,801	$0.00	50,801	$11.28
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	113,430	$0.00	113,430	$18.46
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	141,007	$0.00	141,007	$16.02
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2019-04-01	514,786	$0.00	514,786	$14.20

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
888	2020-02-02	No	4	A	Direct
37,286	2021-02-01	No	4	A	Direct
17,491	2022-02-01	No	4	A	Direct
27,773	2023-02-01	No	4	A	Direct
9,930	2024-03-03	No	4	A	Direct
13,125	2025-03-16	No	4	A	Direct
2,500	2025-03-16	No	4	A	Direct
50,801	2026-03-01	No	4	A	Direct
113,430	2027-02-27	No	4	A	Direct
141,007	2028-02-21	No	4	A	Direct
514,786	2029-01-29	No	4	A	Direct

Footnotes

In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the Separation.
Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation.
This option, granted as an annual performance award, is presently exercisable in full.
This option to purchase 25,212 shares vests in equal installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,500 shares as of the date hereof.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2016.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2017.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2018.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2019.